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Abstract
Non-invasive, self-collected sampling methods for HPV DNA detection in women, which are 
reliable, efficient, and acceptable have the potential to address barriers to cervical cancer screening 
in underserved communities, including low-middle income countries (LMIC) such as the island 
nation of the Federated States of Micronesia (FSM). Urine-based HPV testing has not been 
rigorously evaluated in clinical trials. A pilot community-based participatory randomized control 
research project evaluated use of urine HPV testing as a more culturally- and human resource 
appropriate method of cervical cancer screening in Yap State, FSM. Women participated in a 
cervical screening intervention using pap vs. urine test (N = 217). This manuscript described 
attitudes about screening feasibility and preferences. Stakeholders and women participants were 
interviewed (N = 23), and a survey also evaluated women’s screening preferences (N = 217). 
Qualitative content thematic analysis with multiple coders identified themes from interviews on 
acceptability and feasibility of screening tests. Women research participants were comfortable 
with the urine test (95%), despite limitations in some to provide samples. While 82.0% indicated 
that they felt comfortable with Pap smear, they also preferred a clinician (42%) to do the Pap 
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smear, explaining that they preferred having a trained worker instead of themselves to do tests. 
Women want to be screened but accessibility remains a challenge. Education and training of 
professionals and community members alike will improve clinical skills, research capacity, 
knowledge of screening tests and behaviors including prioritizing HPV screening and testing.
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1. Introduction
1.1. Cervical cancer research in Federated States of Micronesia
Globally, cervical cancer is the third most common cancer in females and the second most 
frequent cause of cancer death, with the majority of cases, including a large proportion of 
late stage cancers, occurring in low-resource settings [1]. Cultural, social and geographic 
barriers impact access to cervical cancer screening in resource limited countries [2]. Human 
papillomavirus infection (HPV), primarily oncogenic types HPV 16 and 18, is the principal 
cause of nearly all cervical cancers [1]. Along with prophylactic vaccinations for HPV, 
screening remains an important component of cervical cancer prevention strategies. HPV 
DNA testing has proven to be an important adjunct to cervical cytology (Pap) screening for 
the early detection of precancerous lesions [3]. Recent studies have demonstrated that HPV 
DNA testing has higher sensitivity than Pap smear testing [4,5]. In March 2014, the U.S. 
Food and Drug Administration advisory panel recommended that HPV DNA testing could 
serve as the primary tool for cervical cancer screening.
The Federated States of Micronesia (FSM) is comprised of 607 volcanic islands and atolls 
scattered over 1 million square miles of the Northwestern Pacific Ocean. The land area totals 
704.6 square kilometers, with 7192 square kilometers of lagoon area. The FSM consists of 
four geographically separate states: Chuuk, Kosrae, Pohnpei, and Yap [6]. FSM is one of the 
most resource-limited US Affiliated Pacific Island (USAPI) jurisdictions, suffers large 
cancer health disparities, but also has some of the strongest community-public health 
partnerships in the USAPI [7].
Micronesian women disproportionately suffer from cancer disparities having among the 
highest rates of cervical cancer in the world including women in Yap State. Yap has an age-
adjusted cervical cancer incidence rate of 20.4 per 100,000 (2007–2012) which is twice the 
incidence rate in the US. Only 28% were diagnosed at Stage 1. Seventy percent of the 
women diagnosed in 2007 or later have died [8]. Funding limitations presently allow 4–10% 
of women to receive cervical cancer screening per year by traditional cytology or using 
visual inspection with acetic acid (VIA) in accordance with the 2010 FSM National 
Standards on Breast and Cervical Cancer Screening [9].
Yap State has demonstrated ability to mobilize women from the main and outer islands to 
tailor cervical cancer education materials, build local capacity for and provide screening, and 
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has been expanding their local capacity for rigorous evaluation of public health programs 
and policies as part of their partnership with Center for Disease Control and Prevention 
(CDC) sponsored program with the University of Hawai‘i (UH). Although resource limited, 
Yap has capacity for appropriate follow-up and treatment of abnormal Pap or VIA and can 
treat Stage 1 cervical cancers on island. Yap State has a well-organized Wa’ab Community 
Health Center network that provides most primary care services on the main island and has 
outer island health assistants trained to provide cervical cancer screening. Annually since 
2008, the Yap Cancer Program has been able to recruitin just one week over 200 women 
from the outer islands and main island for Women’s Health Week cervical cancer screening.
Non-invasive, self-collected sampling methods for HPV DNA detection in women, which 
are reliable, efficient, and acceptable have the potential to address current barriers to cervical 
cancer screening in underserved communities, including low middle income countries 
(LMIC) such as the FSM. Hernandez et al. demonstrated that – self-collection for detection 
of penile HPV was preferable to clinician-collection among U.S. males [10]. CDC-funded 
projects in the USAPI have shown high preference for alternatives to traditional cytology 
based screening [11]. Nonetheless, urine based HPV testing has not been rigorously 
evaluated in clinical trials. The primary objective of this pilot study was to determine the 
acceptability and feasibility of culturally- and health workforce-appropriate cervical cancer 
screening methods, recently published American College of Obstetricians and Gynecologists 
Committee Opinion 624 [12].
1.2. Community based participatory research
A secondary objective of this pilot study was to examine the community based participatory 
research (CBPR) used in the study, how this approach contributed to study completion and 
fidelity, and the extent HPV screening tests are feasible and preferred. CBPR is an approach 
in health promotion research that especially addresses health disparities through the 
engagement and partnership of researchers and community members in all phases of the 
research [13]. This collaboration has the potential to be transformative for all those involved 
wherein partners (e.g. researchers, community residents and service providers) participate in 
multiple aspects of research, from determining goals to developing methods and procedures 
to disseminating results [14].
Pinto et al., developed and described the International Participatory Research Framework 
(IPRF) to advance CBPR. The IPRF presents steps and actions to improve the abilities of 
researchers and practitioners worldwide to systematize the development of research 
partnerships and which can facilitate participatory research in myriad international settings. 
The CBPR literature lacks specificity regarding how to initiate, employ and sustain 
participation when working with partners internationally in developing countries [14]. The 
IPRF serves as a relevant CBPR project framework because the IPRF describes the 
international participatory processes that the collaborative team demonstrated, 
contextualized to the host country, Yap State, FSM.
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2. Materials and methods
2.1. Study design
Women undergoing Pap smear screening in Yap State in the FSM were randomly assigned to 
one of two arms: (1) urine collection followed by clinician cervical sampling; or (2) clinician 
cervical sampling followed by urine collection. Measures included patient- and provider 
acceptability of the sample collection procedures and qualitative data collection to gauge 
readiness for scale-up of HPV DNA testing as the primary screening method as well as 
participation in formal cancer research.
CBPR was included in this study to tailor the randomized control trial methodology to be 
more feasible and meaningful to the communities and researchers. Pinto et al’s IPRF 
comprises four recursive steps: (i) contextualizing the host country; (ii) identifying 
collaborators in the host country; (iii) seeking advice and endorsement from gatekeepers, 
and (iv) matching partners’ expertise, needs and interests [14]. Using this CBPR framework, 
these steps were operationalized in the current HPV CBPR trial. This manuscript reports on 
the CBPR methods and results to ultimately address the acceptability and feasibility of 
cervical vs. urine sample for study participants and project stakeholders (Results of the urine 
versus pap detection of HPV are reported elsewhere.)
Collaborations between the academic researchers and Yap spanning a decade has provided 
best practices on successful collaborations involving community feedback and shared 
decision making used in this project. CBPR was operationalized through a project steering 
committee (SC) in Yap [15] that included members integrally involved in improving cervical 
cancer screening and who have a 10-year history of engagement with the academic 
collaborators. Members of the Yap SC developed the pilot project proposal with the project 
investigators. Monthly calls and frequent reporting were conducted to evaluate the project’s 
process, progress, intended and unintended impact on the health system in Yap, and any 
needed changes were discussed and addressed. The Yap SC contributed to all project 
activities including dissemination. Research protocols and materials were approved by the 
Western Institutional Review Board.
2.2. Recruitment and randomization
The SC and outreach staff recruited 217 Yapese women and as many outer island women as 
feasible. Eligible subjects were women aged 21–65, who had not had a hysterectomy and 
were not currently pregnant, and who had not had cervical cancer screening within the past 
three years or who had had abnormal screening results within the past three years. –This 
population was targeted in order to yield higher numbers of HPV DNA+ women than would 
be derived from a previously screened population. Additionally, targeting these women 
provided tremendous benefit to Yap and appropriately directed resources toward the 
population at highest risk for cervical cancer.
Trained staff met with potential study participants, obtained written informed consent and 
ensured completion of the exit survey after specimen collection was completed. Study 
subjects were randomized into cervical cell or urine collection groups. Upon conclusion of 
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the study visit, subjects were provided with an incentive worth approximately $15 (i.e., 
project logo-printed multi-purpose bag).
Cervical cell specimens were collected by a trained clinician using liquid based cytology 
(ThinPrep). Up to 30 mL of first catch urine specimens were collected by the participant in 
the restroom using a labeled sterile collection cup. Specimens were stored in the clinic 
refrigerators then transported daily to the hospital lab where they were refrigerated until 
shipment. Samples were batched and shipped to the UH.
2.3. Data sources and collection
Data on the acceptability of cervical cancer screening methods were derived from a self-
administered or staff administered survey, focus groups and key informant interviews. The 
survey was distributed to the participants to complete after specimen collection, where staff 
verbally translated where needed. Questions included basic demographic and social 
characteristics, prior cervical cancer screening and HPV vaccine history, and acceptability 
issues-including preference of urine versus clinician collection.
A qualitative researcher who has also worked with Yap SC members on cancer and chronic 
disease projects conducted on site key in person informant interviews (KII) and focus groups 
discussion (FGD) at the end of the study. These data sources would provide descriptive data 
about the method of cervical cancer screening, feedback on the project itself, and issues 
affecting sustainability. The SC recruited women research participants, providers and public 
health staff. Three sessions were conducted: One FGD with eight cervical cancer screeners, 
individual one-on-one KIIs with nine steering committee members and other stakeholders, 
and one FGD with six women from the community who were research participants.
The FGDs and KIIs were guided by semi-structured questions developed and pilot tested by 
the project team. The questions for the cervical cancer screeners and SC members contained 
ten items and other stakeholder interview questions contained nine items. Questions were 
similar and covered the extent participants were trained and prepared for their roles, lessons 
learned about the process and research, suggestions to make cervical cancer screening 
available in Yap, and research participation interests.
The project coordinator and research assistant served as translators when needed for KIIs 
and FGDs during the women research participant focus group. The qualitative researcher 
facilitated all sessions using the FGD and KII guides, asking probing questions when 
needed. All sessions were audio recorded. The qualitative researcher and project coordinator 
served as note takers for both of the FGDs thus producing two sets of notes for these 
sessions. One set of nine notes, corresponding to each KII was produced. The notes 
comprised the datasets for the qualitative content thematic analysis. Each focus group lasted 
approximately one hour and stakeholder interviews ranged from 15 to 30 min.
2.4. Data analysis
Descriptive statistics were used to analyze the survey and demographic data.
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Notes form the audio recordings of the FGDs and KII were transcribed using key phrases 
and not verbatim because responses were straightforward and used to inform the program. 
However informative quotes were transcribed verbatim in the notes.
A thematic content analysis was conducted with transcripts for each dataset, i.e., cervical 
cancer screener FGD, SC member KIIs, and women research participant FGD, and thematic 
codes were developed inductively by each question response. For example, for the steering 
committing KII question: Although there are still a few more women needed to get to the 
required 200, are there any lessons that you’ve learned so far? Responses covered themes 
related to “organization and paperwork,” “infrastructure,” and “new techniques,” as 
examples. Themes were identified inductively because the qualitative researcher was not a 
clinician or clinical researcher. Codebooks that contained thematic codes for each question, 
description of the code, and examples were developed for each of the data sets.
Once the set of thematic codes were developed into the codebook, two Hawaii based coders 
with varying backgrounds on HPV topics and community culture were trained on coding the 
transcripts, using coding forms. Because both FGDs, i.e., cervical cancer screeners and 
women research participants, had two sets of notes, each set was also coded by each coder. 
The qualitative researcher reviewed the coding results from the two coders by examining 
agreement in codes. Where there was disagreement, the qualitative researcher reviewed the 
transcript passage, and decided on the thematic code.
3. Results
3.1. Women research participant survey
Surveys were completed by all 217 – research participants. The age distribution of 
participants were as follows: – 20–29: 17.1%, 30–39: 30.4%, 40–49: 29.9%, 50+: 23.5%. 
Over seventy eight percent were residing on the main island of Yap during the time of 
screening. A history of Pap smear screening was reported by 39.6% of participants and 
59.5% reported prior screening by either Pap smear and/or visual inspection with acetic acid 
(VIA).
Ninety five percent and 82.0% of women indicated that they felt comfortable with urine and 
pap smear collection, respectively. The most common reason for discomfort with the pap 
smear was that participants were scared though only 8.8% indicated this reason for feeling 
uncomfortable. The most popular screening test was having a doctor or nurse do the pap 
smear (44.2%), and the second popular test was providing their own urine sample (38.3%).
3.2. Cervical cancer screeners and steering committee members
Key themes discussed by the SC members and cervical cancer screeners are presented in 
Tables 1 and 2. Overall the themes discussed by the SC members and cervical cancer 
screeners corroborated.
3.2.1. Project preparation—Cervical cancer screeners and steering committee members 
indicated that they felt prepared for the project, though in different ways. SC members 
described that the discussions and meetings on the project were helpful and that the set 
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schedule made the implementation easy and convenient. Screeners commented that they had 
equipment and supplies readily available
“The system was prepared for the project.” [cervical cancer screener}
“Management went well. Communicative team, good team. UH is very clear with 
what it wants. Then set the tone. What needs to be done, who needs to be involved, 
constant communication. We never got together internally. Conference call was 
main way to communicate. Then had subgroups through emails. Everyone copied 
on emails.” [SC member]
3.2.2. Challenges—Challenges to the project for both groups were regarding urine 
collection. For screeners, challenges also included the resources and procedures and required 
to conduct, store, and transportation involved with the pap test.
“We have lights, gooseneck lamps here [on Main], but in Outer Islands, we had a 
hard time because room was hot during the drought, there was no power, the plastic 
specula were difficult to use. Let’s bring metallic ones from main-island next time.”
For steering committee members, challenges were that there was additional work, and that it 
was time consuming given time provided to complete it. “The time was too short for the 
project. We have own jobs duties.”
3.2.3. Training—For all project participants, training in general research and on specific 
aspects of conducting research was requested. Both groups also wanted training on 
conducting specific cervical cancer screening procedures.
“More training so that they are well versed to discuss about the research” [cervical 
cancer screener]
“More training on pelvic exams. Right now only doctors do it” [cervical cancer 
screener]
The screeners and SC members’ most common response as to how UH could have better 
prepared members through the research project was having more time to perform, prepare 
for and conduct the project. At the same time, many of the SC members in their interviews 
individually indicated that UH staff prepared them well. “It went very well, had supplies, 
conference calls.”
3.2.4. Future research—The screeners and SC members were willing to participate in 
future research projects with UH and other universities though some stated that the research 
needs to truly benefit and impact their community. One benefit that both groups identified is 
that research can identify ways to address the resource limitations and also bring in 
resources such as supplies and equipment, and funding. The screeners also indicated that 
while they would welcome research collaborations, it may require a commitment given all 
their present responsibilities. This comment was consistent with the SC members’ feedback 
about challenges of time constraints in carrying this project. Research topics that both 
groups identified to address were d vitamin A deficiency, STIs, and youth health promotion.
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“Research would bring more exposure that Yap is doing different things. Others 
will want to work with us because of our research experience.” [SC member]
“Yes if there is likelihood that we’ll take it further than just researching us for UH 
and for others.” [SC member]
“Hard to do screening if there are no supplies. Good to study is it necessary or the 
same” [cervical cancer screener]
3.2.5. Screening availability—Project participants recommended health worker trainings 
to conduct screenings as a way to make them more widely available to women throughout 
Yap. The cervical cancer screeners and steering committee members also suggested having 
more accessible screenings with the screeners recommending having dedicated screening 
days so that women will expect it and attend. SC members’ suggestions were consistent with 
learning that women are interested in getting screened, and they recommended providing 
more accessibility to address having screenings more widely available in Yap.
“In Outer Islands—techniques are difficult—Need to have other ways of testing to 
be easier. We needed equipment—ice pack, no electricity. Accessibility.” [SC 
member]
“Smallness gives good us coverage. Health workers can integrate education on 
screening as part of their work to talk about screening. Offer a focused time frame. 
Everyone can participate in a yearly screening event.” [cervical cancer screener]
3.3. Women research participant focus group
Results from the women research participant FGD helped to contextualize and explain the 
quantitative results. Also, comments from women research participants corroborated with 
the comments from screeners and SC members. Common themes discussed are listed in 
Table 3. Themes of early detection and prevention, desire to stay health and have quality of 
life, and wanting to know about their cancer status were brought up for several questions.
“Early detection is better than late for cervical cancer. This cancer has been a 
problem in Yap because a lot of women have died from it. Late detection won’t 
help”
“I have it yearly. They [other women] don’t all take advantage. They’re not 
comfortable with the procedure. It’s available. Women need to take charge of own 
health. They’re not aware of what prevention they could have, not educated but if 
so, they will know risks and motivated to get tested.” [research participant]
These comments corroborated with SC members indicating that women in Yap want to get 
screened but that future screenings need to be more accessible.
Research participants discussed their preferences on having skilled and knowledgeable 
screeners, corroborating with comments on training needs to be able to conduct screenings. 
This preference also explains why almost half of the research participants chose having a 
clinician doing the pap as the preferred method of screening. The most important factor on 
what type of screening method that the women preferred appeared to be that health 
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professionals, or in this case screeners, are well trained, even over participants’ privacy 
concerns.
“I’d rather have the expert do the sampling than me”
“I’d prefer to have someone well-trained, especially to make me feel at ease with 
such an uncomfortable procedure”
Additionally, since about a third of women research participants preferred the urine test, 
challenges, e.g., places to provide the sample, participants being able to provide samples, 
expressed by the cervical cancer screeners regarding collection should be addressed.
4. Discussion
The acceptability and feasibility of any cervical cancer screening initiative requires feedback 
from all stakeholders involved in implementing an initiative as well as the project 
participants. As a first ever randomized control trial in Yap on HPV screening, the CBPR 
approach allowed for timely project completion according to protocols, because, as 
expressed by SC members, they were involved in the planning of each step. Cervical cancer 
prevention and detection requires multi-level approaches: training of the health workforce, 
having services accessible and available for the community, and continuing research to 
improve the health promotion system. The accessibility and availability of well-trained 
screeners should be widely communicated and promoted through all channels, i.e., 
interpersonal such as through friends and family, professional such as through health 
workers, and community wide media.
Stakeholders’ exposure to and participation in this pilot research trial fostered their desire to 
participate in future research and to consider research’s direct benefit on their community. 
Research and collaborations with universities were welcomed especially because research 
could address how to overcome resource limitations in providing screenings. Two concerns 
to be addressed are to ensure that results will benefit and impact the community and that 
adequate time and personnel are available to conduct the research. Suggested priority 
research topics are vitamin A deficiency, STIs, and youth health promotion.
5. Conclusions
Wallerstein et al. identified pathways by which CBPR processes result in particular 
outcomes. Wallerstein et al.’s CBPR conceptual model suggests that if structural and 
relational partnership processes are effective within their dynamic contexts, then these 
partnership decisions will have an impact on and change intervention design, and the 
research [16]. Furthermore prior successful international collaboration steps including those 
operationalized in this current research project aligned with Pinto et al.’s IPRF [14].
Yap State has a small but strong public health and quality improvement infrastructure along 
with established collaborations abroad. This contributed to this research project 
operationalizing CBPR according to existing frameworks and ultimately the timely 
completion of the first ever research trial in FSM and objectives. At the same time project 
procedures were acceptable and feasible to professional and community stakeholders.
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This research project is the first study using an experimental design comparing self-collected 
urine and clinician-collected samples for the detection of cervical HPV infection in females 
in the FSM. These results on acceptability and feasibility of HPV screenings provides 
valuable information for future research and/or demonstration projects which utilize 
alternatives to cytology based screening in resource-limited, geographically dispersed island 
settings like those throughout the Pacific and Caribbean. Because screening methods are 
acceptable and feasible, future projects have the potential to be sustainable and improve 
cervical cancer screening across throughout Yap State. Finally these findings and HPV 
screening acceptability and feasibility may serve as a model to also implement projects 
throughout the rest of the USAPI. Self-collected urine HPV DNA testing holds promise as a 
culturally acceptable, less resource-intensive method of detecting risk for cervical dysplasia 
for underserved populations in the US and internationally.
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Table 1
Cervical Cancer Screeners Themes Discussed.
Thematic Code Description Ave # times coded
Which test is better Project purpose is comparing tests 5.8
Time Needed More time to prepare and conduct project 4.9
Prepared-general General feedback that they felt prepared 4.8
Collaborations Would benefit from or enjoy research collaborations 4.3
Overall prevalence Abnormal paps, high cervical cancer rates 4.0
Supplies-equipment Had supplies & equipment 3.5
Dedicated screening Dedicate a day, time, weekend to do screening, e.g., Women’s Health Week 3.3
Specific cervical procedure Need Trainings on cervical cancer screening procedures 2.5
Collecting urine Challenges in collecting urine from participants, in Main & Outer Islands 2.0
Specific NCDs Name NCDs (cardiac, hypertension, diabetes) 2.0
Positive results How to handle positive results 1.3
Impact Willing to do research if there is real contribution and purpose 1.3
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Table 2
Steering Committee Member Themes Discussed.
Thematic Code Description Ave # times coded
General research Want general training on research 5.5
Resources In need of money, supplies 5.0
Time-prep Needed more time to prepare and conduct project 4.0
Other research Suggested research topics: Vitamin A, deficiency, Rota virus, STIs 3.5
Organization Paperwork Planning, paperwork, scheduling, coordinating 3.0
Time-duties Work was time consuming 2.5
New Research is new in Yap 2.5
Collaborations Would benefit from or enjoy research collaborations 2.0
Duties-time Willing for future research but acknowledges time commitment given jot responsibilities 2.0
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Table 3
Women Research Participants Themes Discussed.
Well trained Participants like when they feel that screener is well trained 6.8
Professional screener Prefer professionals to do screening because they are the experts 5.0
Detection-Prevention Detection early and prevent cancer is important 3.5
Waiting Being told to wait for results was challenging 3.0
Liked screener Liked the nurse or screener 2.8
Good instructions Liked clear instructions on how to provide sample 2.8
Free Suggest Provide free screenings which is already being done, and other ways to offset costs 2.8
Convenient- free Get screened Because it’s available, convenient, free 2.0
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